{
    "symbol": "BNTX",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-09 12:57:18",
    "content": "  Our ability to supply our COVID-19 vaccine, the planned next steps in our pipeline programs, the timing for enrollment initiation, completion and reporting of data from our preclinical studies and our clinical trials, the timing of and our ability to obtain and maintain regulatory approval for our product candidates and other risks described in our filings made with the U.S. Securities and Exchange Commission, including our most recent annual report on Form 20-F. As actual results could differ from those we currently anticipate, you are therefore cautioned not to place undue reliance on any forward-looking statements, which speak only as of today, shared today during this conference call and webcast."
}